Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
6.79
-0.01 (-0.15%)
Sep 4, 2025, 4:00 PM - Market closed
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$308,481
Profits / Employee
-$146,370
Market Cap
631.77M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,700 | 0 | - |
| Dec 31, 2023 | 2,700 | 100 | 3.85% |
| Dec 31, 2022 | 2,600 | 200 | 8.33% |
| Dec 31, 2021 | 2,400 | -300 | -11.11% |
| Dec 31, 2020 | 2,700 | 0 | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MYGN News
- 10 hours ago - Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology - GlobeNewsWire
- 1 day ago - New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression - GlobeNewsWire
- 8 days ago - Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - GlobeNewsWire
- 17 days ago - Myriad Genetics Appoints Ben Wheeler Chief Financial Officer - GlobeNewsWire
- 22 days ago - New Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the Results - GlobeNewsWire
- 4 weeks ago - Myriad: HCT In Oncology Continues To Deliver Increased Volume And Revenue Growth - Seeking Alpha
- 4 weeks ago - Myriad Genetics, Inc. (MYGN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Myriad Genetics Reports Second Quarter 2025 Financial Results; Raises 2025 Revenue Guidance Following Positive Business Momentum - GlobeNewsWire